Mechanisms of Brain Manganese Homeostasis and Manganese-induced Parkinsonism
Mechanisms of Brain Manganese Homeostasis and Manganese-induced Parkinsonism
批准号:
10318895
负责人:
Cherish A Taylor
金额:
$3.18万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-07-01 至 2022-05-31
关键词:
AcademiaAddressAdultAwardBasal GangliaBehaviorBehavioralBiological AssayBrainCell NucleusChildCognitive deficitsDevelopmentDiseaseEndodermEnvironmental ExposureEnvironmental HealthEnvironmental Risk FactorExhibitsExposure toFellowshipFunctional disorderGene ExpressionGenesGenetic TranscriptionGoalsHomeostasisImmunohistochemistryKnock-outKnockout MiceKnowledgeLiverManganeseManganismMental disordersMentorsMentorshipMetalsMethodsMicrodialysisModelingMotorMutationNerve DegenerationNeurobiologyNeuronsNeurophysiology - biologic functionNeurosciencesNeurosciences ResearchOccupationalOccupational ExposureOralParkinson DiseaseParkinsonian DisordersPathologyPatientsPhenocopyPhenotypeResearchResearch PersonnelResearch Project GrantsRiskRoleSchizophreniaScienceSourceSupervisionSystemTestingTexasTherapeuticToxicologyTrainingUniversitiesWorkalpha synucleinaustinautism spectrum disordercareerclinically significantcollaborative environmentdifferential expressionexperimental studygastrointestinal systemhuman diseasein vivoinsightinterdisciplinary approachloss of function mutationmotor deficitmotor disorderneurodevelopmentneurotoxicneurotoxicityneurotoxicologyneurotransmissionnovelrelating to nervous systemsymposiumtherapy developmenttranscriptome sequencingwillingness
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Manganese (Mn) is an essential metal required for normal neural development and function; however,
at elevated levels, it is neurotoxic. Adults and children exposed to Mn through environmental or occupational
sources exhibit incurable motor and cognitive deficits. Mn overexposure is also associated with a-synuclein
aggregation and increased risk for developing Parkinson’s Disease. Mn presents an environmental health
concern, but the mechanisms of brain Mn homeostasis and the effects of Mn on brain function remain are not
fully understood. Upon overexposure, Mn builds up in the basal ganglia; however, the specific neuronal targets
of Mn are unclear. A major question in the field is whether Mn primarily effects catecholaminergic, particularly
dopaminergic, or GABAergic neurons in the basal ganglia. The proposed study aims to address this question
by selectively increasing Mn in catecholaminergic and GABAergic neurons which was not previously possible.
Homozygous mutations in the Mn efflux transporter, SLC30A10, resulted in increased brain Mn and
Mn-induced parkinsonism. The current proposal leverages the discovery of SLC30A10 to understand the
mechanisms of brain Mn homeostasis and the effects of increased Mn in all or some neurons. Using full-body,
pan/neuronal/glial, liver-, and endoderm-specific Slc30a10 knockout mice, we discovered that under basal
conditions, brain Mn levels are primarily regulated by activity of SLC30A10 in the digestive system, while its
activity in the brain protected against neurotoxicity during Mn overexposure. This work established the
predominance of SLC30A10 in regulating brain Mn levels and presented a novel method for studying Mn
neurotoxicity. Subsequent work will use pan-neuronal/glial, catecholaminergic, and GABAergic Slc30a10
knockouts to selectively increase Mn in all, catecholaminergic, or GABAergic neurons. This study will test the
hypothesis that catecholaminergic, but not GABAergic, Slc30a10 knockouts mimic the phenotype observed in
pan-neuronal/glial knockouts. Proposed experiments will assay for Mn-induced changes in motor function,
neurodegeneration, neurotransmission, and gene expression under normal conditions and during an oral Mn
exposure relevant to human disease. The proposed study uses a multidisciplinary approach to further elucidate
how brain Mn homeostasis is regulated and how excess brain Mn impacts the catecholaminergic and
GABAergic systems. Proposed studies will be performed under the supervision of sponsor, Dr. Somshuvra
Mukhopadhyay and co-sponsor, Dr. Robert Messing at the University of Texas at Austin (UT Austin). Dr.
Mukhopadhyay is an expert in Mn toxicology, and Dr. Messing has a well-established career in neuroscience.
Their combined expertise and the collaborative environment at UT Austin are critical for the successful
completion of the proposed study and for providing the training and mentorship necessary for the applicant’s
goals of a career in academia and neuroscience research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of glycosylation in environmental and genetic schizophrenia risk
-
批准号:10667373
-
项目类别:
-
资助金额:$8.61万
-
财政年份:2021
-
负责人:Cherish A Taylor
-
依托单位:
海外基金